Cite

HARVARD Citation

    Palandri, F. et al. (n.d.). P1011: PREDICTORS OF COVID-19 DISEASE AND SURVIVAL TO COVID-19 IN MPN PATIENTS TREATED WITH RUXOLITINIB. HemaSphere. pp. 901-902. [Online]. 
  
Back to record